Bluefin Bio Medicine
Biotechnology, 32 Tozer Road, Beverly, , 1915, Massachusetts, United States, 11-50 Employees
Phone Number: 92********
Who is BLUEFIN BIOMEDICINE
Founded in 2016, Bluefin BioMedicine is a privately held company focused on the detection of novel cancer antigens and the development of next-generation medicines for the treatment of ca...
Read More
-
Headquarters: 32 Tozer Road, Beverly, Massachusetts, 1915, United States
-
Date Founded: 2016
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from BLUEFIN BIOMEDICINE
Bluefin BioMedicine Org Chart and Mapping
Email
Phone
Similar Companies to Bluefin BioMedicine
HepatoChem
-
1-10
-
$ 1 Million to 5 Million
HighRes Biosolutions
-
51-200
-
$ 25 Million to 50 Million
Integral Biosystems
-
11-50
-
$ 5 Million to 10 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Bluefin BioMedicine
Answer: Bluefin BioMedicine's headquarters are located at 32 Tozer Road, Beverly, , 1915, Massachusetts, United States
Answer: Bluefin BioMedicine's phone number is 92********
Answer: Bluefin BioMedicine's official website is https://bluefinbiomed.com
Answer: Bluefin BioMedicine's revenue is $5 Million to $10 Million
Answer: Bluefin BioMedicine's SIC: 2834
Answer: Bluefin BioMedicine has 11-50 employees
Answer: Bluefin BioMedicine is in Biotechnology
Answer: Bluefin BioMedicine top competitors include: HepatoChem , HighRes Biosolutions , Integral Biosystems
Answer: Bluefin BioMedicine contact info: Phone number: 92******** Website: https://bluefinbiomed.com
Answer: Founded in 2016, Bluefin BioMedicine is a privately held company focused on the detection of novel cancer antigens and the development of next-generation medicines for the treatment of cancer. We are using proprietary, cutting-edge protein detection methods to interrogate complex tumor specimens and discover differentially expressed cancer antigens that can be targeted with antibody therapies. Our focus is on cancers with clear unmet medical need and building a robust portfolio of therapeutic candidates that address those needs.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month